Immuron Plans Phase 2 Trial for IMM-529 following FDA review
05 sept. 2024 11h54 HE
|
Immuron Limited
Key Points Immuron completes pre-IND meeting with FDA on the development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI)Previous clinical trial data on...
Retrieve Medical, Inc. and OnPoint Healthcare Partners, Inc., Announce Revolutionary Integration Partnership
01 août 2024 13h35 HE
|
Retrieve Medical, Inc.
BEDMINSTER, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Retrieve Medical, Inc. (retrievemedical.com) today announced a technology partnership with OnPoint Healthcare Partners, Inc....
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation
19 avr. 2024 13h21 HE
|
Retrieve Medical, Inc.
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation
Retrieve Medical Holdings, Inc. (RMHI) Announces Study Update Results Utilizing Retrieve Dx ™ Software
22 mars 2024 08h00 HE
|
Retrieve Medical, Inc.
RETRIEVE MEDICAL HOLDINGS, INC. (RMHI) ANNOUNCES STUDY UPDATE RESULTS UTILIZING RETRIEVE DxTM SOFTWARE
Retrieve Medical Holdings, Inc. Forges Partnership with Louisiana Health System Hospitals
26 févr. 2024 09h00 HE
|
Retrieve Medical, Inc.
Retrieve Medical Holdings, Inc. Forges Partnership with Louisiana Health System Hospitals
Retrieve Medical, Inc. Announces Groundbreaking Patent for Enhancing Electronic Health Records
07 févr. 2024 11h32 HE
|
Retrieve Medical, Inc.
Retrieve Medical, Inc. Announces Groundbreaking Patent for Enhancing Electronic Health Records
Microbiome Therapeutics Market Size to Hit $813.38 Million, Globally, by 2030 - Exclusive Report by The Insight Partners
10 nov. 2023 05h43 HE
|
The Insight Partners
Pune, India, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Microbiome therapeutics, also referred to as microbiome-based therapies or interventions, are medical procedures that try to use the human microbiome's...
Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
05 sept. 2023 07h59 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has...
The Importance of Accurate Coding and Documentation in Value-Based Care
25 juil. 2023 09h00 HE
|
CHESS Health Solutions
Winston-Salem, NC, July 25, 2023 (GLOBE NEWSWIRE) -- Much has been written about the gaming of risk coding to drive additional revenue, particularly in the Medicare Advantage (MA) program. From a...
AHIMA Microcredentials Empower Health Information Professionals to Thrive in a Skills-Based Job Market
20 juil. 2023 07h11 HE
|
American Health Information Management Association (AHIMA)
CHICAGO, July 20, 2023 (GLOBE NEWSWIRE) -- The American Health Information Management Association (AHIMA) is proud to announce the launch of six innovative microcredentials specifically designed for...